SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-024154
Filing Date
2021-02-16
Accepted
2021-02-16 16:31:16
Documents
63
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm214592d1_10q.htm 10-Q 559022
2 EXHIBIT 31.1 tm214592d1_ex31-1.htm EX-31.1 8943
3 EXHIBIT 31.2 tm214592d1_ex31-2.htm EX-31.2 8618
4 EXHIBIT 32.1 tm214592d1_ex32-1.htm EX-32.1 5062
5 EXHIBIT 32.2 tm214592d1_ex32-2.htm EX-32.2 5345
  Complete submission text file 0001104659-21-024154.txt   4394311

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nnvc-20201231.xml EX-101.INS 995852
7 XBRL TAXONOMY EXTENSION SCHEMA nnvc-20201231.xsd EX-101.SCH 46903
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nnvc-20201231_cal.xml EX-101.CAL 40483
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nnvc-20201231_def.xml EX-101.DEF 174919
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nnvc-20201231_lab.xml EX-101.LAB 307419
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nnvc-20201231_pre.xml EX-101.PRE 298177
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

IRS No.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36081 | Film No.: 21639302
SIC: 2834 Pharmaceutical Preparations